Floatz logo

Therapeutic Asset Ratings

1,055 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Trametinib
Thyroid Gland Papillary Carcinoma
Cancer Research UKP2/3B (56)
VEMURAFENIB
Plasma Cell Myeloma
Cancer Research UKP2/3B (56)
VIPIVOTIDE TETRAXETAN GALLIUM GA-68
Prostate Cancer
University of WashingtonP2/3B (56)
Vorinostat
Acute Lymphoblastic Leukemia
Tanja Andrea GruberP2/3B (56)
Vyxeos
Acute Myeloid Leukemia
Jazz PharmaceuticalsP2/3B (56)
ZINC SULFATE
Sickle Cell Disease
Indiana UniversityP2/3B (56)
[18f]f-resca-rt4
Carcinoma
RenJi HospitalP2/3CCC (55)
[18f]f-resca-rt4
Thyroid Cancer
RenJi HospitalP2/3CCC (55)
[18F]F-RESCA-T4
Carcinoma
RenJi HospitalP2/3CCC (55)
[18F]F-RESCA-T4
Thyroid Cancer
RenJi HospitalP2/3CCC (55)
4-phenylbutyrate
Intrahepatic Cholestasis
Children's Hospital of Fudan UniversityP2/3CCC (55)
[68ga]ga-nota-rt4
Carcinoma
RenJi HospitalP2/3CCC (55)
[68ga]ga-nota-rt4
Thyroid Cancer
RenJi HospitalP2/3CCC (55)
[68ga]ga-nota-t4
Carcinoma
RenJi HospitalP2/3CCC (55)
[68ga]ga-nota-t4
Thyroid Cancer
RenJi HospitalP2/3CCC (55)
ALECTINIB
Neuroblastoma
Cancer Research UKP2/3CCC (55)
Allopurinol
Hepatic Encephalopathy
Tanta UniversityP2/3CCC (55)
Anamorelin
Lung Cancer
M.D. Anderson Cancer CenterP2/3CCC (55)
Atezolizumab
Endometrial Cancer
Cancer Research UKP2/3CCC (55)
ATORVASTATIN
Hepatic Encephalopathy
Tanta UniversityP2/3CCC (55)
Avastinib
Myelodysplastic Syndrome
Ruijin HospitalP2/3CCC (55)
Azacitidine
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
National Cancer Institute (NCI)P2/3CCC (55)
Azacitidine
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)P2/3CCC (55)
Azacitidine
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P2/3CCC (55)
Azacitidine
T-Cell/Histiocyte Rich Large B Cell Lymphoma
National Cancer Institute (NCI)P2/3CCC (55)
Showing 701 to 725 of 1,055 assets
PreviousPage 29 of 43Next